Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Topical Ketotifen 0.25% for Secondary VestibulodyniaFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, female reproductive system disorder, vulvar disease, vulvodyniaRecruitingPhase 22026-03-18NCT07257029

2 results · Page 1 of 1

Swipe the table sideways for more columns.

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
The Center for Vulvovaginal DisordersTampaUnited States1
The Center for Vulvovaginal Disorders - New YorkNew YorkUnited States1
The Center for Vulvovaginal Disorders - Washington, DCWashington D.C.United States1